Literature DB >> 11837558

Parenteral nutrition-associated liver complications in children.

Imad F Btaiche1, Nabil Khalidi.   

Abstract

Parenteral nutrition is a life-saving therapy for patients with intestinal failure. It may be associated with transient elevations of liver enzyme concentrations, which return to normal after parenteral nutrition is discontinued. Prolonged parenteral nutrition is associated with complications affecting the hepatobiliary system, such as cholelithiasis, cholestasis, and steatosis. The most common of these is parenteral nutrition-associated cholestasis (PNAC), which may occur in children and may progress to liver failure. The pathophysiology of PNAC is poorly understood, and the etiology is multifactorial. Risk factors include prematurity, long duration of parenteral nutrition, sepsis, lack of bowel motility, and short bowel syndrome. Possible etiologies include excessive caloric administration, parenteral nutrition components, and nutritional deficiencies. Several measures can be undertaken to prevent PNAC, such as avoiding overfeeding, providing a balanced source of energy, weaning parenteral nutrition, starting enteral feeding, and avoiding sepsis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11837558     DOI: 10.1592/phco.22.3.188.33553

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  17 in total

1.  Use of parenteral fish oil to reverse cholestasis induced by parenteral nutrition in infants with intestinal failure: single-centre case series.

Authors:  Denise Reniers; Irina Rajakumar; Suzanne Ratko; Paul Atkison
Journal:  Can J Hosp Pharm       Date:  2012-01

2.  Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?

Authors:  Jae Il Shin; Ran Namgung; Min Soo Park; Chul Lee
Journal:  Eur J Pediatr       Date:  2007-04-14       Impact factor: 3.183

3.  Alteration of canalicular transporters in a mouse model of total parenteral nutrition.

Authors:  Yuko Tazuke; Daniel H Teitelbaum
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

Review 4.  Intestinal transplantation: a review.

Authors:  Chirag Sureshchandra Desai; Khalid Mahmood Khan; Raffaele Girlanda; Thomas M Fishbein
Journal:  Indian J Gastroenterol       Date:  2012-08-31

5.  Parenteral nutrition-associated liver disease: a retrospective study of ursodeoxycholic Acid use in neonates.

Authors:  Maxime Thibault; Jessica McMahon; Guillaume Faubert; Julie Charbonneau; Josianne Malo; Ema Ferreira; Ibrahim Mohamed
Journal:  J Pediatr Pharmacol Ther       Date:  2014-01

Review 6.  Short bowel syndrome in children: current and potential therapies.

Authors:  Victor Uko; Kadakkal Radhakrishnan; Naim Alkhouri
Journal:  Paediatr Drugs       Date:  2012-06-01       Impact factor: 3.022

7.  Risk factors for parenteral nutrition–associated liver disease following surgical therapy for necrotizing enterocolitis: A Glaser Pediatric Research Network Study [corrected].

Authors:  Debora Duro; Paul D Mitchell; Leslie A Kalish; Cami Martin; Maggie McCarthy; Tom Jaksic; James Dunn; Mary L Brandt; Kerilyn K Nobuhara; Karl G Sylvester; R Lawrence Moss; Christopher Duggan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-05       Impact factor: 2.839

8.  Ethanol Lock Efficacy and Associated Complications in Children With Intestinal Failure.

Authors:  Ethan A Mezoff; Lin Fei; Misty Troutt; Kim Klotz; Samuel A Kocoshis; Conrad R Cole
Journal:  JPEN J Parenter Enteral Nutr       Date:  2015-02-23       Impact factor: 4.016

Review 9.  Complications associated with parenteral nutrition in the neonate.

Authors:  Kara L Calkins; Robert S Venick; Sherin U Devaskar
Journal:  Clin Perinatol       Date:  2014-06       Impact factor: 3.430

10.  Total parenteral nutrition leads to alteration of hepatocyte cell cycle gene expression and proliferation in the mouse.

Authors:  Yuko Tazuke; Barbara E Wildhaber; Hua Yang; Joseph Washburn; Daniel H Teitelbaum
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.